2013 North American Agricultural Safety Summit
September 25-27, 2013 Minneapolis, Minnesota
Dialog with agricultural producers, manufacturers, employers and their organizational leadership!
Theme: Translational Research in Agricultural Safety and Health
Global Health 2013, The Second International Conference on Global Health Challenges
November 17 - 22, 2013 - Lisbon, Portugal
Colocated with other events part of DataSys 2013
Tracks:
FUNDAMENTALS
Foundations in global health informatics; Computational health; Software for health; Independent living technologies; ICT and health; Platform interoperability; Semantic interoperability; Diagnosis systems; Applied health informatics; User interfaces and visualization
TECHNOLOGY
Bio-medical semantics; Bio-medicine; Disease biomarker prediction; Applications of bio-nano technology; Body networks; Mobile healthcare; Ubiquitous healthcare
TRENDS
Clinical epigenetic; Long term health conditions; Ambient assisted; Genetics; Virtual reality in medicine surgery; Clinical trials; Computational and knowledge management on proteomics and genomics; Drug design, disease diagnosis and control
PRACTICE
Nursing; Patient-centered care; Personalized medicine; Pervasive health; Homecare; Pharmaceutical services
ALTERNATIVE
Biomedicine; Natural medicine; Preventive medicine; Chronic diseases following; Home surveillance
CHALLENGES
Security aspects and access control on medical data; Data management in pervasive context; Data quality assurance and provenance; Patient flow models in hospitals; Clinical data analysis; Information visualization of medical data
GLOBAL
eHealth initiatives; Social medicine; Health global accessibility; Epidemic spreading and control; Health Education; Providing health in remote areas; Decision support within healthcare; Ethical aspects in eHealth; Healthcare plans and patient benefits; Synchronization of federal regulations; Availability of medication; Community health services
Innovations in Cardiovascular Interventions (ICI Meeting 2013)
“Innovations in Cardiovascular Interventions (ICI) - From Idea to Reality" will be held on December 1-3, 2013 in Tel-Aviv, Israel
The upcoming meeting will focus on innovative technology and therapies in the cardiovascular area and related exciting disciplines and will cover all stages of the innovation process from the bench to the patient bedside.
This year we will continue to watch closely the dynamic and vibrant area of valvular interventions and the many innovations under investigation for treating cardiac valvular pathology using percutaneous techniques or combined surgical and interventional pathways.
This year we will continue to review the regulatory, ethical and financial aspects of new devices and continue the Mobile health track that was an exciting topic last year which will continue with a special flavour within the scientific program.
Who should attend: Clinical cardiologists, innovative scientists, biomedical engineers, financial investors seeking opportunities and members of cutting edge teams in major companies in this field, who want to be part of the future of interventional cardiology.
Contact Us
ICI Secretariat:
Dan Knassim Ltd.
60 Medinat Hayehudim st.
P.O.Box 4195
Herzliya 46766
Israel
Tel/fax: 972-3- 5767739
Email: secretariat@icimeeting.com
5th International Conference on Fixed Combination in the Treatment of Hypertension, Dyslipidemia and Diabetes Mellitus
21-24 November, 2013 Bangkok, Thailand
Fixed combination has recently made a comeback as an initial therapy in the treatment of hypertension. The additive or synergistic effect of combination therapy fully lowers blood pressure in patients who tend to have less than full response to one component only. Antihypertensive monotherapy does not address the multifactorial nature of hypertension as a disease with many pathways; using more than one drug makes more therapeutic sense, as combined agents cover more than one etiology.
Importance of anti-diabetic and anti-lipidemic combinations should be emphasized as well: Many patients with diabetes mellitus may also be treated with dual pharmacological therapy as fixed combination: two or more drugs acting on different pathophysiological process is often necessary to reach early and sustained achievement of individualized glycemic targets. At the same time choosing the safest option to avoid hypoglycemia is of paramount importance compared with loose pill, both statin and anti-diabetic combination therapies may also have better adherence, improved satisfaction and lower drug costs.
The conference is intended for experts in the fields of diabetes, hypertension, dyslipidemia, internal medicine, cardiology, endocrinology, nephrology, hyperlipidemia, family medicine, primary care physicians, nurse practitioners and physicians’ assistants. All are invited to explore the current and future role of fixed combinations in the treatment of hypertension, dyslipidemia and diabetes.
List of Topics
• Treatment Simplification and Compliance
• FDCs as First Step Treatment
• FDC in Secondary Prevention
• FDCs of Antihypertensive and Antidiabetic Drugs
• FDCs of Antihypertensive and Lipid Lowering Drugs
• FDC in the Elderly and Very Elderly
• Ambulatory BP in the Assessment of FDC Efficacy
• Home BP in the Assessment of FDC Efficacy
• Combinations with Thiazides. Chlortalidone vs HCTZ
• ACE Inhibitors and Diuretics FDC
• ACE Inhibitors and Calcium Channel Blockers FDC
• ARBs and Diuretics FDC
• ARBs and Calcium Channel Blockers FDC
• Triple Drug Combinations
• The Polypills
• FDCs as Generic Drugs
• Guidelines
• FDCs in Different Countries
• Regulatory Aspects
• Cost Issues
Contact Us
Conference Organizers
Paragon Conventions
18 Avenue Louis-Casai
1209 Geneva, Switzerland
Tel: +41 (0)22 533 0948
Fax: +41 (0)22 580 2953
General Enquiries
Noa Beer-Raveh - Project Manager
fixed2013@fixedcombination.com
Fax: +41 (0)22 580 2953
5th Jerusalem International Conference on Health Policy
Health Policy in Times of Austerity: Provider Perspectives, Quality Assurance & Public Acceptance
June 3-5, 2013 Jerusalem, Israel
This conference takes place at a time when societies and governments are still reeling from the after effects of the financial crisis that created conditions of recession and exposed underlying weaknesses in the world economic system. Health systems not only have not been spared. But, beyond the need to consider ways of dealing with austerity, they can also play a leading role in contributing to social vitality and development of new modes of policy, regulation and management that can cope with new realities.
In this conference we will confront the following key challenges:
1. How should quality and value in health care be conceptualized;
2. What are the implications of the economic crisis for population health
3. How can institutions and governance be reshaped to deal with the current crisis and prepare for its long term consequences?
Leading experts in management and governance, health economics, health policy and regulation, population health, and quality and performance measurement will be addressing the conference on these issues plenary sessions. In addition, thematic sessions will delve more deeply into these tough, but fascinating problems, and we expect to emerge with new ideas for the future based on the solid contributions of all the participants.
5th Pharmaceutical Sciences World Congress (PSWC)
13-16 April 2014 Melbourne, Australia
Join leading pharmaceutical scientists from around the world to showcase cutting edge research and up-and-coming developments under the theme: ‘Pharmaceutical Sciences - beyond 2020’.
The Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP) is pleased to bring the 5th PSWC to Melbourne, Australia in 2014. Not only will the Conference uphold its world-renowned reputation for top quality speakers, symposia and posters, but will once again provide a forum for the most extensive international network of pharmaceutical scientists to impact the future of scientific research and global healthcare.
The programme will discuss scientific discovery and progress in the context of such issues as emerging markets, with a focus on Asian pharmaceutical sciences and the regulatory framework that supports them and a special stream on pharmacoepidemiology.
The 2014 PSWC will also foster a new generation of visionary and ground-breaking pharmaceutical scientists via a special stream for students.
Contact: congress@fip.org
European Association of Centres of Medical Ethics Annual Conference
September 19-21, 2013 Bochum, Germany
“Personalised medicine” – medicine for the person? Ethical challenges for medical research and practice
The Institute for Medical Ethics and History of Medicine, Ruhr University Bochum, Germany, and the European Association of Centres of Medical Ethics (EACME) will organise the EACME annual conference in 2013. The conference will be organised in cooperation with the Centre for Medical Ethics Bochum (ZME e.V.) and supported by the Research Ethics Committee of the Medical Faculty, Ruhr University Bochum.
Contact details and further information:
President of the Conference: Prof. Dr. med. Dr. phil. Jochen Vollmann
Scientific Secretary: PD Dr. med. Jan Schildmann, M.A.
Institute for Medical Ethics and History of Medicine
Ruhr University Bochum
Markstrasse 258a
44799 Bochum
Germany
Tel.: 0049 234-32-23394
Fax: 0049 234-32-14205
E-mail: info(at)eacme2013.org
Conference website: www.eacme2013.org
7th National Smokeless & Spit Tobacco Summit
“Empowering Advocates for the Next Frontier in Smokeless Tobacco”
August 6 – 8, 2013 The University of Montana – Missoula, Montana
Presented by University of Montana The College of Health Professions and Biomedical Sciences
The 7th National Smokeless and Spit Tobacco Summit is the ONLY national conference dedicated to addressing the health and social issues attributed to smokeless and spit tobacco use.
Public health practitioners, researchers, medical and dental care providers, American Indian Tribal leaders, youth leadership professionals and more will gather to inform and motivate unified policies and programs aimed at reducing smokeless and spit tobacco use.
A National Steering Committee has assembled to plan the Summit, and has identified the following goals for the 3-day Summit:
Focus national attention on smokeless and spit tobacco addiction as a critical public health issue.
Bring a united voice to smokeless tobacco advocates in the fields of prevention, research, and treatment.
Empower attendees with viable public health solutions to take action in support of programs and policies that reduce smokeless and spit tobacco use in their communities.
Share current treatment guidelines and promising approaches for dental health providers to utilize in their oral health practice.
Update health practitioners and public health workers about addiction and cessation issues.
Controlling the use of dangerous smokeless and spit tobacco products requires a comprehensive effort, involving many different sectors of the community.
To this end, the Conference Committee will be promoting the Summit to the following groups:
Tobacco Prevention & Cessation Specialists
Public Health Officials
Tribal Health Officials
Dental Care Providers & Association Reps
Medical Providers & Association Reps
Voluntary Health Organizations
Health Scientists, Researchers, Academia
Health Science Writers
Health Communication Organizations
American Indian Tribal Leaders
K-12 Health & P.E. Educators
Military Leaders
Parks & Recreation Leaders
Youth Leadership Professionals
Sports & Athletic Leaders
Mining Industry Officials
Law Enforcement Leaders
Clergy
Pharmaceutical Industry Representatives
General Inquires
Mikel Robinson
info@smokelesstobaccosummit.com
(406) 546-8584
Association for the Advancement of Automotive Medicine 57th Annual Conference
September 22-25, 2013 Quebec City, Canada
AAAM's conference is regarded as the most authoritative forum on current knowledge in traffic injury control and presents active and published research in multidisciplinary appraoches to automotive-related trauma in areas such as epidemiology, biomechanics, treatment and management, transport psychology, accidentology, and human factors.
Who attends?
AAAM's conference is attended by 150 experts, including emergency physicians or nurses orthopedic surgeons, trauma surgeons, neurosurgeons, radiologists, physiatrists, urologists, emergency medical providers, epidemiologists, biomechanics or vehicle design engineers, automotive engineers, crash investigators, health policy specialists, internists, psychologists, sociologists, or other human factor specialists, accident reconstructionists, or road safety specialists.
Meeting highlights
The meeting will begin with the 4th Annual Student Symposium Sunday, September 22, in which student researchers present their works in progress.
4th Colombian Meeting and International Conference on Air Quality and Public Health
August 13-16, 2013, Bogota, Colombia
The fourth version of the Colombian Meeting and International Conference on Air Quality and Public Health (CASAP 2013) will be held in the city of Bogota. This fourth edition of the event will be an excellent opportunity to learn the state of the art with regard to the study and control of air pollution, modeling and implementation of public policies, particularly through plenary sessions which will be conducted by national and international experts who are highly respected and recognized. Additionally, there will be several breakout sessions where representatives from universities, research centers, government agencies and consulting firms will show the latest developments on these issues worldwide.
